Navigation Links
WWMR, Inc. Announces New Website to Showcase Research Case Studies
Date:5/5/2008

SAN FRANCISCO, May 5 /PRNewswire/ -- Drawing on fifteen years of focused and solution-oriented research, WWMR, Inc. a leading strategic consultancy serving the Biotech, pharmaceutical, medical device and diagnostics industries, announces the launch of their new website showcasing more than 25 Research Case Study summaries. (http://www.wwmr.com).

WWMR, Inc. is a marketing research and strategic consulting firm with global capabilities, known for conducting focused and solution-oriented research across all phases of drug development.

Speaking on the occasion, Susan Olsen, President, WWMR, Inc., said that "Redesigning the website has provided us with an exciting opportunity to both provide content that will demonstrate the breadth of our capabilities, as well as educate those interested in learning about specific project approaches we've successfully carried out. We'd like to put our experience to work for those who may need to investigate drug development and launch topics that we have experience with."

The Custom Projects section of the new website lists appropriate types of marketing research for each stage of drug development, from Preclinical/Phase I through Launch. Attached to each type of research project is a document describing the Challenge, Solution and Impact for one or more projects. Specifics include descriptions of the scenario, objectives, and special challenges of the research, as well as the methodology and deliverables. To obtain more detail (which is available for each Case Study Summary), contact WWMR directly.

In support of its extensive services and growing client base, WWMR, Inc. has an experienced staff of Senior Consultants and Market Research Analysts. WWMR, Inc. also continues to expand its line of EP Publications over the coming year, with:

-- Pain Clinic Monitor -- a monthly audit of 100 carefully selected Pain

Clinics, reporting treatment details for 10 patients, as well as

detailing visits for up to five representatives.

-- 2008 U.S. Neuropathic Pain Report -- this fourth edition will feature

two new chapters -- Fibromyalgia and Neuropathic Cancer Pain.

The new website reaffirms WWMR, Inc.'s commitment to providing cost-effective business decision support to its pharmaceutical, Biotech, medical device and diagnostics clients who want to optimize the revenue potential of their product portfolio through effective business decisions.

WWMR, Inc. designs and executes research which brings clarity, reveals innovative opportunities and provides deeper understanding across all phases of drug development. This enables our clients to:

-- Demonstrate the commercial value of product/partnering opportunities

-- Optimize the revenue potential of their product portfolio

-- Identify and evaluate additional business opportunities

For more information about WWMR, Inc.'s services please contact Michelle Nordstrom, Office and Production Manager at the Corporate Headquarters:

WWMR, Inc.

2929 Campus Drive

Suite 200

San Mateo, CA 94403

Phone: (888) 947-2339

(650) 513-0300

Fax: (650) 312-1570

Web: http://www.WWMR.com

Email: Michelle_Nordstrom@WWMR.com


'/>"/>
SOURCE WWMR, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
2. Making the Outdoors Safer for Communities: the American Academy of Dermatology Announces 2008 AAD Shade Structure Program Grant Recipients
3. Herley Announces Settlement Agreement with U.S. Government
4. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
5. Authentidate Holding Corp. Announces Results From Annual Meeting of Stockholders
6. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
7. Lifetime Television Proudly Announces October Marquee Event Original Movie, Living Proof Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr.
8. Hear Indiana Announces Talk*Walk*Run 2008
9. Parkview Christian Center Announces September 2008 Opening of Outreach Ministry Building
10. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
11. AVEENO(R) Announces Sponsorship and Kick-Off of The Skin Cancer Foundations Road to Healthy Skin Tour Presented by AVEENO(R) and Rite Aid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Groth Family Insurance, a Washington-based ... is initiating a charity drive to support the family of Cindy Hendrickson, a ... , On October 29th of this year, Cindy Hendrickson swerved to avoid ...
(Date:12/9/2016)... ... 09, 2016 , ... The Justin Veatch Fund announced Thursday that ... the film Whispering Spirits and its discussion guide for use by all ... tool in the war against teen drug abuse. NCADD is the oldest anti-addiction ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name ... New York, NY, on December 3rd, to benefit Holy Name Medical Center's programs ... event, which raised over $1 million - the largest event in the Center's ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Insights beginning January 1, 2017. The name change aligns the entire company ... and improving health care quality. , “We are very proud of the achievements ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic ... Informatics . , Results of the comparative usability study demonstrate that a dictation-based ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016  Harmar Mobility, LLC announced today that Steven ... of the Board of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... ... Mr. Dawson,s executive career includes ... across a variety of industries. He brings to the company deep ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... vaccines market to grow at a CAGR of 6.83% during the ... the growth prospects of the global travel vaccines market for 2016-2020. ... from the sales of various vaccines administered to actively immunize meningococcal ...
(Date:12/8/2016)... 2016 IRIDEX Corporation (NASDAQ: IRIX ) ... of common stock, $0.01 par value (the "Offering" with such ...  The final terms of the Offering will depend on market ... can be no assurance as to whether or when the ... the net proceeds it will receive from this offering for ...
Breaking Medicine Technology: